Sep 11
|
Bristol Myers' (BMY) Pulmonary Fibrosis Drug Positive in Phase II
|
Sep 11
|
Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
|
Sep 9
|
Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study
|
Sep 9
|
Big Pharma’s Battle With the Biden Administration Could Have Legs
|
Sep 7
|
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$4.1b market cap drop, institutional owners may be forced to take severe actions
|
Sep 7
|
Bristol Myers Squibb Celebrates a Decade of Its Coast 2 Coast 4 Cancer Cross-Country Bike Ride in Support of the V Foundation for Cancer Research
|
Sep 6
|
Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know
|
Sep 6
|
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
|
Sep 6
|
Why Is Axsome (AXSM) Up 8.6% Since Last Earnings Report?
|
Sep 6
|
15 Stocks to Buy with Steady Dividends
|
Aug 13
|
15 Worst Performing Healthcare Stocks in 2023
|
Aug 13
|
He Was a Scientist. Could He Find a Drug to Treat His Own Disease?
|
Aug 11
|
Pharma ETFs in Focus Post Q2 Earnings
|
Aug 11
|
Possible Bearish Signals With Bristol-Myers Squibb Insiders Disposing Stock
|
Aug 10
|
Bristol Myers Squibb Inducted into the Billion Dollar Roundtable, Expands Supplier Diversity Efforts
|
Aug 10
|
Bristol Myers Squibb Enters Into $4 Billion Aggregate Accelerated Share Repurchase Agreements
|
Aug 8
|
Bristol Myers Squibb Launches Clear Understanding Campaign to Reveal the Plain Truth About Living with Moderate to Severe Plaque Psoriasis
|
Jun 30
|
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
|
Jun 30
|
Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC
|
Jun 29
|
5 High-Yielding Dividend Stocks That Are Bargain Buys
|